Commentary: Time to review all the evidence for hormone replacement therapy

British Medical Journal

Volumn 330, Issue 7487, 2005, Pages 345-

  Crawford, Fay ^a   Langhorne, Peter ^b  

^a Tayside Centre for General Practice   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

BRAIN PROTECTION; BREAST CANCER; CALCIUM INTAKE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; ESTROGEN THERAPY; EVIDENCE BASED MEDICINE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LOW FAT DIET; MENOPAUSE; META ANALYSIS; MONOTHERAPY; NOTE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STROKE; SYSTEMATIC REVIEW; VEIN THROMBOSIS; CHEMICALLY INDUCED DISORDER; CONTROLLED CLINICAL TRIAL; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

CEREBROVASCULAR ACCIDENT; HORMONE REPLACEMENT THERAPY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 13844314056     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Bath PWM, Gray LJ. Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 2005;330:342-4.
2. Grady D. Postmenopausal symptoms-therapy for symptoms only. N Engl J Med 2003;348:1835-7.
3. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, et al. Effect of estrogen plus progestin on stroke in post menopausal women. The women's health initiative: a randomised trial. JAMA 2003;289:2673-84.
4. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA for the HERS Research Group. Quality of life and depressive symptoms in post-menopausal women after receiving hormone replacement therapy. JAMA 2002;287:591-7.
5. Hays J, Ockene J, Brunner RL, Kotchen JM, Manson JE, Paterson RE, et al. Effects of estrogen plus progesterone on health related quality of life. N Engl J Med 2004;384:1839-54.